These results suggest that the mesenchymal microenvironment, which is comprised of cells such as MSCs and the fd-ECM, downregulates several tumorigenic signaling pathways and inhibits the proliferation of cancer cells through various processes and not just a single pathway. This evidence concerns the gene ELP1 and cancer.